Cencora Raises 2026 EPS Outlook as Quarterly Profit Climbs
CONSHOHOCKEN, PA — Cencora Inc. (NYSE: COR) raised its fiscal 2026 earnings outlook after third-quarter revenue increased 5.1% to $84.8 billion and operating income climbed 29%, as growth in pharmaceutical …
Cencora Raises 2026 EPS Outlook as Quarterly Profit Climbs Read More